British Cannabis will become the sole and exclusive manufacturer and distributor of Elixinol CBD products in the UK for the next three years.
The company has entered into an exclusive agreement with Elixinol Wellness, the wholly-owned subsidiary of Elixinol Wellness Pty Ltd, to sell its extensive range of CBD supplements and cosmetics across the UK.
The British Cannabis (CBD Health Foods Ltd) agreement – which marks a pivotal agreement in the course of the UK cannabinoid market – will enable Elixinol to continue to distribute its brand in the UK, whilst handing over the UK operations and associated cost.
Read more: Powered by British Cannabis
Elixinol Global CEO, Oliver Horn, commented: “We are delighted about our partnership with BRITISH CANNABIS who are the most established manufacturer and distributor of branded and white label CBD products in the UK. BRITISH CANNABIS’ Canabidol brand is widely distributed in UK pharmacies, demonstrating the company’s credentials and capabilities to build brands in sophisticated retail channels.
“British Cannabis’ manufacturing capability also allows us to manufacture Elixinol products in the UK and thus create a more efficient supply chain solution. Through the partnership with BRITISH CANNABIS, UK consumers will now continue to be able to buy their favourite Elixinol products and we are very excited to see the brand continue following many years of building the brand.”
With regulatory developments in the UK being complex to navigate, Elixinol made the decision earlier this year to cease its trading in the UK and EU markets.
British Cannabis CEO, Tom Whettem, said: “It is an honour to be asked to continue the legacy of Elixinol here in our home market.
“The prospect of a dynamic partnership between Australia’s leading global CBD range and the UK’s premier manufacturer has excited both myself and our leadership team. The ranges from the companies complement each other in several ways and continuing the legacy of Elixinol galvanizes us.
“With the security of our Novel Foods dossiers, the potential to take this reinforced portfolio to market makes for a very solid proposition for retailers and provides the CBD supplements consumer with great choices.”
The shared aim between the Elixinol and British Cannabis – which is the largest independently owned, producer, manufacturer and distributor of legal cannabis-derived products in the UK – is to improve revenues across the board, whilst building on the legacy set by Elixinol’s founders over 10 years ago.
Elixinol’s simplified business model is now focusing on the US markets, educating and selling its branded products through licensing agreements in the UK and Europe and expanding distribution of Elixinol branded hemp-derived products through reputable distributors as key markets open across the rest of the world.
[activecampaign form=31]
